CompaniesImmunOs Therapeutics
ImmunOs Therapeutics logo

ImmunOs Therapeutics

active
Schlieren, Switzerland
Founded 2014
Website
About

Immunotherapy

Areas of Focus

Categories

Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibody
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

140

By Phase

PHASE1: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
Today
NCT05763004
Hover over trial bars to see details

Recent Trials

NCT05763004Lead Sponsor
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
PHASE1Recruiting
140 participants
Started: Mar 15, 2023 · Completed: May 31, 2025
Locations (1)
Headquarters
Schlieren, Switzerland
Map

Loading map...